Binge ethanol exposure increases the Krüppel-like factor 11-monoamine oxidase (MAO) pathway in rats: Examining the use of MAO inhibitors to prevent ethanol-induced brain injury

Neuropharmacology. 2016 Jun:105:329-340. doi: 10.1016/j.neuropharm.2016.01.024. Epub 2016 Jan 22.

Abstract

Binge drinking induces several neurotoxic consequences including oxidative stress and neurodegeneration. Because of these effects, drugs which prevent ethanol-induced damage to the brain may be clinically beneficial. In this study, we investigated the ethanol-mediated KLF11-MAO cell death cascade in the frontal cortex of Sprague-Dawley rats exposed to a modified Majchowicz 4-day binge ethanol model and control rats. Moreover, MAO inhibitors (MAOIs) were investigated for neuroprotective activity against binge ethanol. Binge ethanol-treated rats demonstrated a significant increase in KLF11, both MAO isoforms, protein oxidation and caspase-3, as well as a reduction in BDNF expression in the frontal cortex compared to control rats. MAOIs prevented these binge ethanol-induced changes, suggesting a neuroprotective benefit. Neither binge ethanol nor MAOI treatment significantly affected protein expression levels of the oxidative stress enzymes, SOD2 or catalase. Furthermore, ethanol-induced antinociception was enhanced following exposure to the 4-day ethanol binge. These results demonstrate that the KLF11-MAO pathway is activated by binge ethanol exposure and MAOIs are neuroprotective by preventing the binge ethanol-induced changes associated with this cell death cascade. This study supports KLF11-MAO as a mechanism of ethanol-induced neurotoxicity and cell death that could be targeted with MAOI drug therapy to alleviate alcohol-related brain injury. Further examination of MAOIs to reduce alcohol use disorder-related brain injury could provide pivotal insight to future pharmacotherapeutic opportunities.

Keywords: BDNF; Binge ethanol; Caspase-3; Kruppel-like factor 11 (KLF11); Monoamine oxidase (MAO); Neurotoxicity; Protein oxidation; Rats; Transcription factor.

MeSH terms

  • Animals
  • Binge Drinking / enzymology*
  • Brain Diseases / chemically induced
  • Brain Diseases / prevention & control*
  • Brain-Derived Neurotrophic Factor / metabolism
  • Caspase 3 / metabolism
  • Cell Death
  • Central Nervous System Depressants / administration & dosage
  • Central Nervous System Depressants / antagonists & inhibitors
  • Central Nervous System Depressants / toxicity*
  • Ethanol / administration & dosage
  • Ethanol / antagonists & inhibitors
  • Ethanol / toxicity*
  • Male
  • Monoamine Oxidase / genetics*
  • Monoamine Oxidase Inhibitors / therapeutic use*
  • Neuroprotective Agents / pharmacology
  • Neurotoxicity Syndromes / prevention & control
  • Oxidative Stress / drug effects
  • Pain Measurement / drug effects
  • Rats
  • Rats, Sprague-Dawley
  • Signal Transduction / drug effects*
  • Trans-Activators / drug effects*
  • Trans-Activators / genetics*

Substances

  • Brain-Derived Neurotrophic Factor
  • Central Nervous System Depressants
  • KLF11 protein, rat
  • Monoamine Oxidase Inhibitors
  • Neuroprotective Agents
  • Trans-Activators
  • Ethanol
  • Monoamine Oxidase
  • Casp3 protein, rat
  • Caspase 3